MEB
Director Trades
| Date | Director | Value | 
|---|
Company News

Medibio completes first ilumen wellbeing pilot with Compass Group
Health technology company MediBio (ASX: MEB) has completed the first of four planned pilot programs using its ilumen corporate health and wellbeing product, with the assistance of employees from UK-based food service company Compass Group. Under the terms of a commercial agreement signed in July, Medibio offered ilumen on a voluntary basis to employees of […]

Medibio partners with Australian wellness company to develop workplace mental well-being solution
Health technology company Medibio Limited (ASX: MEB) has announced it will join forces with digital corporate wellness developer WellteQ to provide industry with a robust employee health solution which integrates mental well-being. The companies will work towards incorporating Medibio’s ilumen digital mental well-being assessment into WellteQ’s digital wellness platform, and hope to make the new […]

Medibio signs two pilot contracts with Compass Group for its ilumen product
Health technology company Medibio (ASX: MEB) has taken an assertive step towards commercialising its corporate health product called ‘ilumen’ after signing a commercial agreement with UK company Compass Group to begin the first of two pilot programs. The agreement means ilumen will be deployed in supporting mental well-being for Compass’ employees in the UK and globally. […]

Medibio welcomes industry stars Rio Tinto and AFL as clients
Mental health technology company Medibio (ASX: MEB) has announced further commercial contracts with industry-leading names such as Rio Tinto (ASX: RIO), the Australian Football League (AFL) and the Aurecon Jacobs Joint-Venture (AJJV) responsible for delivering the West Gate tunnel project in Victoria. The AFL intends to implement Medibio’s technology to assist with evaluating current players […]

Medibio strikes a deal with Australia’s leading Catholic healthcare provider
Dual-listed mental health technology company Medibio (ASX: MEB) has struck a potentially lucrative commercial deal with St John of God Health Care (SJGHC) to deploy ‘Medibio Inform’, Medibio’s new product launched earlier this month as part of its newly established corporate health division. Medibio said that the new division has the “potential to deliver a […]

Medibio clinches CE Marking accreditation for mental health platform
Mental-health technology company Medibio (ASX: MEB) has received European CE Marking certification for its stress-phenotype and sleep-assessing product and platform from independent assessor DQS Med. Medibio managing director and chief executive officer Jack Cosentino called the accreditation further validation of the company’s technology and product offering. “Acquiring CE Marking represents the successful completion of a […]

Medibio bags second clinical trial agreement with world-leading Mayo Clinic
Digital mental health company Medibio Limited (ASX: MEB) has inked a five-year clinical trial agreement with the United States’ top hospital: Mayo Clinic. According to Medibio, it is the first company to use objective biometrics to assist in diagnosing and treating mental health disorders including depression. The objective testing system facilitates more accurate screening, diagnosing, […]
Company Videos
No videos found.